Analysis of Circulating Tumor Markers in Blood
Recruiting · NCT04025541 · Interventional (participants receive a specific treatment) · Lead sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
View the official record on ClinicalTrials.gov →Interventions studied
Blood samplingBlood sampling C11 + FFPEBlood sampling C12Blood sampling C3Blood sampling C4/7/10/13Blood sampling C5Blood sampling C6Blood sampling C8Blood sampling C9
What this trial is about
The circulating tumoral biomarkers in the blood are the object of numerous researches for several decades. The potential clinical interests of these circulating biomarkers are diagnostic, prognostic, predictive of the efficiency of targeted therapies (according to the mutational profile of the cancer), and could allow the study of the mechanisms of resistance under process. In the multiplicity of these blood potential biomarkers joins a permanent evolution of the technological means used to detect them/to quantify, as well as to estimate their clinical utility.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patient presenting an invasive tumoral pathology (proved or suspected), whatever is the location or the stage,
- Man or woman ≥ 18 years,
- Obtaining of the informed consent signed before any procedure of specific preselection on approval.
Exclusion criteria
- Private persons of freedom or under guardianship,
- Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons,
- Pregnant woman and/or breast-feeding,
- Unaffiliated patient to Social Protection System,
Where it is running
4 locations listed.
- Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle - Montpellier, France
- ICM - Montpellier, France
- Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle - Montpellier, France
- ICM - Montpellier, France